Jennison Associates
AGN

Jennison Associates’s Allergan plc AGN Stock Holding History

Jennison Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-189,271
Closed -$31.7M – 710
2019
Q2 		$31.7M Sell
189,271
-575,118
-75% -$79.6M 0.03% 276
2019
Q1 		$112M Sell
764,389
-730,292
-49% -$106M 0.11% 109
2018
Q4 		$200M Sell
1,494,681
-284,978
-16% -$46.7M 0.22% 63
2018
Q3 		$339M Buy
1,779,659
+139,195
+8% +$25.6M 0.31% 50
2018
Q2 		$273M Sell
1,640,464
-301,920
-16% -$48.5M 0.27% 54
2018
Q1 		$327M Sell
1,942,384
-156,888
-7% -$26.3M 0.33% 51
2017
Q4 		$343M Sell
2,099,272
-2,157,147
-51% -$387M 0.34% 50
2017
Q3 		$872M Sell
4,256,419
-1,242,800
-23% -$289M 0.89% 32
2017
Q2 		$1.34B Sell
5,499,219
-697,208
-11% -$164M 1.42% 17
2017
Q1 		$1.48B Buy
6,196,427
+1,628,172
+36% +$379M 1.59% 13
2016
Q4 		$959M Sell
4,568,255
-2,707,948
-37% -$561M 1.07% 27
2016
Q3 		$1.68B Buy
7,276,203
+878,672
+14% +$215M 1.81% 9
2016
Q2 		$1.48B Buy
6,397,531
+1,895,779
+42% +$437M 1.62% 12
2016
Q1 		$1.21B Buy
4,501,752
+88,822
+2% +$25.4M 1.27% 17
2015
Q4 		$1.38B Sell
4,412,930
-1,408,411
-24% -$419M 1.35% 19
2015
Q3 		$1.58B Sell
5,821,341
-965,773
-14% -$297M 1.62% 9
2015
Q2 		$2.06B Sell
6,787,114
-199,559
-3% -$59.5M 1.89% 6
2015
Q1 		$2.08B Buy
6,986,673
+1,720,502
+33% +$491M 1.91% 6
2014
Q4 		$1.36B Buy
5,266,171
+1,857,116
+54% +$464M 1.27% 13
2014
Q3 		$823M Buy
3,409,055
+1,983,316
+139% +$444M 0.76% 42
2014
Q2 		$318M Sell
1,425,739
-366,834
-20% -$76M 0.29% 77
2014
Q1 		$369M Sell
1,792,573
-224,046
-11% -$44.4M 0.35% 68
2013
Q4 		$339M Buy
+2,016,619
New +$315M 0.33% 67
2013
Q3 		– Sell
-1,615,800
Closed -$204M – 727
2013
Q2 		$204M Buy
+1,615,800
New +$183M 0.23% 96

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jennison Associates's AGN Position: Q3 2019 in Review

Jennison Associates sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 189,271 shares — an estimated $31.7M sold.

Jennison Associates first reported a position in AGN in Q2 2013 and held it in 24 quarters. The position peaked at $2.08B in Q1 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Jennison Associates reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Jennison Associates sold 189,271 Allergan plc shares in Q3 2019, an estimated $31.7M.
  • Jennison Associates first reported a position in Allergan plc in Q2 2013 and held it in 24 quarters.
  • Jennison Associates's Allergan plc position peaked at $2.08B in Q1 2015.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Jennison Associates's 13F filing for Q3 2019, filed 8 Nov 2019.